LY

Healthcare · Pharmaceuticals

Lyka Labs Ltd (LYKALABS)

₹93.41

Mkt cap
₹341 Cr
P/E ratio
—
P/B
3.52
Div yield
0.00%
ROE
−10.20%
ROCE
−5.98%
EPS (TTM)
—
Book value
₹27
52W range
44–93
Sector
Healthcare

Price history

Previous close

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages [1]

NSE LYKALABSBSE 500259
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsBullish
52-week range
0.00% from high
₹93
₹44+111.81% from low₹93
Current
₹93.41
Prev close
₹91.58
Day
+2.00%
Price performance
1D
+2.00%
1W
+10.39%
1M
+13.03%
3M
+29.41%
6M
+52.46%
1Y
+6.23%
YTD
+13.38%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales27.9932.5627.7730.1141.1633.8033.4333.0336.6630.7328.0342.3144.20
YoY Sales growth+9.64%+82.72%+24.87%+31.60%+47.05%+3.81%+20.38%+9.70%-10.93%-9.08%-16.15%+28.10%+20.57%
Expenses23.8225.6925.7526.4036.2128.6129.3529.3539.2029.0834.4837.7640.68
Operating Profit4.176.872.023.714.955.194.083.68-2.541.65-6.454.553.52
OPM %14.90%21.10%7.27%12.32%12.03%15.36%12.20%11.14%-6.93%5.37%-23.01%10.75%7.96%
Other Income-0.180.540.320.560.030.830.820.631.091.160.610.420.62
Interest1.191.281.070.650.540.610.470.850.790.820.701.011.02
Depreciation3.592.842.901.761.761.831.422.112.152.152.042.012.05
Profit before tax-0.793.29-1.631.862.683.583.011.35-4.39-0.16-8.581.951.07
Tax %-22.78%38.60%28.22%30.65%28.36%24.30%32.89%26.67%-26.65%-6.25%-6.06%-5.13%-18.69%
Net Profit-0.491.78-2.091.291.912.702.030.99-3.22-0.15-8.072.051.27
EPS in Rs-0.150.54-0.630.400.590.760.500.26-0.940.00-2.130.570.36
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.00% · closed higher next day 1 of last 2
 Q1FY27Q2FY27†
Broadcast10 Aug '2630 Oct '26◦
Earnings day+1.99%−2.00%
+1 day+1.89%−1.34%
+5 days+1.93%+5.22%
+15 days+12.92%—
+30 days+29.91%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
58.45%Promoter
Promoters58.45%
FIIs0.15%0.02
DIIs0.66%
Public40.73%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Lyka Labs₹93.41—3410.00%1+138.39%44+20.57%−5.98%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings